Abacus Global Management, Inc. - 9.875% Fixed Rate Senior Notes due 2028
Fundamentals0.0
Price Action4.0
News Sentiment0.0
AI Rating
4.0
Key Drivers
- Higher lows
- Tight range
- Support hold
AIAI Summary
4.0
ABXL should be viewed as a long-duration, milestone-driven optionality trade rather than a fundamentals-backed stock, with meaningful upside only if clinical/regulatory progress de-risks the pipeline soon, while persistent losses, weak technicals, and financing/dilution risk remain the key threats if execution slips.
Catalyst
Dilution
Biotech
Price Chart
Loading chart...
Financial Metrics
-
Revenue (TTM)-
Net Income (TTM)-
EPS (Q)-
MCAPDeep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
0.0
Price Behavior
4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.
Key Price Behavior Insights:
- •Higher lows
- •Tight range
- •Support hold
ABXL remains mildly upward and range-bound, holding above $25.10 with resistance near $25.54–$25.55, but the move is still narrow and lacks strong momentum.
cautiouslybullish
rangebound
Support Level: $25.10–$25.15
Resistance Level: $25.54–$25.55
Brief dip to $24.92 on 2026-04-15 quickly reversed, then prices recovered above support
Sentiment & News
0.0
Similar Companies in Financial Services
Other companies in the same sector with AI ratings
SEZL
Sezzle Inc.
8.0
Fundamental9.0
Technical8.0
Sentiment0.0
V
Visa Inc.
8.0
Fundamental9.0
Technical6.0
Sentiment8.0
FCFS
FirstCash Holdings, Inc
8.0
Fundamental7.5
Technical7.5
Sentiment8.0
SEIC
SEI Investments Company
7.8
Fundamental8.7
Technical7.0
Sentiment8.0
ENVA
Enova International, Inc.
7.6
Fundamental7.5
Technical5.5
Sentiment8.0